We found that whole-tumor gene expression of T cell marker factors (CD8 and IFN-γ) and chemokines (CXCL9 and CXCL10) were significantly enhanced after ICT treatment, while inflammatory factors (IL6, IL10 and TNF-α) were reduced (Figure 7F). The gene discussed is CXCL9; the disease is neoplasm.